Edition:
United Kingdom

Aarti Drugs Ltd (ADRG.NS)

ADRG.NS on National Stock Exchange of India

613.25INR
4:11am GMT
Change (% chg)

Rs6.25 (+1.03%)
Prev Close
Rs607.00
Open
Rs617.00
Day's High
Rs617.00
Day's Low
Rs611.20
Volume
371
Avg. Vol
23,186
52-wk High
Rs785.00
52-wk Low
Rs447.80

Chart for

About

Aarti Drugs Limited is a pharmaceutical company. The Company offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antifungals, antibiotic, antidiabetic, sedative and vitamins. Its products under APIs include Aceclofenac, Diclofenac Potassium,... (more)

Overall

Beta: 1.30
Market Cap(Mil.): Rs12,355.59
Shares Outstanding(Mil.): 23.86
Dividend: 1.00
Yield (%): 0.19

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-India's Aarti Drugs Dec-Qtr Consol Profit Rises

* DEC QUARTER CONSOL PROFIT 233.3 MILLION RUPEES VERSUS PROFIT 178.5 MILLION RUPEES YEAR AGO

13 Feb 2018

BRIEF-India's Aarti Drugs Approves Buyback Of Equity Shares

* SAYS BUYBACK OF EQUITY SHARES WORTH UP TO 240.6 MILLION RUPEES Source text - http://bit.ly/2m7c2c3 Further company coverage:

08 Jan 2018

BRIEF-Aarti Drugs To Consider Proposal Of Buyback Of Fully Paid-Up Equity Shares Of Co

* TO CONSIDER PROPOSAL OF BUYBACK OF FULLY PAID-UP EQUITY SHARES OF CO Source text for Eikon: Further company coverage:

03 Jan 2018

BRIEF-India's Aarti Drugs Sept-qtr profit falls

* Sept quarter profit 180.3 million rupees versus 201 million rupees year ago

13 Nov 2017

Earnings vs. Estimates